John A. Kirby

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 449 citations · Full text

Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease

Karolina A. Rygiel, Helen Robertson, Helen Marshall et al. · Laboratory Investigation · 2007 · 235 citations · Full text

Fibrosis, Hepatic Disorders, Hepatology +14

The Hemodynamic Mechanisms of Lung Injury and Systemic Inflammatory Response Following Brain Death in the Transplant Donor

Vassilios S. Avlonitis, C.H. Wigfield, John A. Kirby et al. · American Journal of Transplantation · 2005 · 166 citations · Full text

Acute Lung Injury, Lung Transplantation, Lung Inflammation +21

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 158 citations · Full text

Hepatology, Pretreatment Prediction, Biliary Tract +7

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis

Gaik W. Tew, Jason A. Hackney, Deena L. Gibbons et al. · Gastroenterology · 2015 · 153 citations · Full text